BACKGROUND: Although several reports have discussed the potential of the indocyanine green (ICG) fluorescence technique, its effectiveness and limitations have not been fully evaluated. For the accurate detection of sentinel lymph node (SLN) in cutaneous melanoma, which can arise in a wide variety of sites throughout the body, it is important to detect the SLN sites prior to skin incision. The purpose of this study was to evaluate the ICG fluorescence technique in the preoperative setting. PATIENTS AND METHODS: We classified the detection process of SLN biopsy into three surgical stages: 'before skin incision,' 'after skin incision,' and 'ex vivo.' We retrospectively reviewed 93 node fields in 86 patients who underwent SLN biopsies using ICG and conventional techniques. RESULTS: The detection rate using ICG at the 'before skin incision,' 'after skin incision,' and 'ex vivo' surgical stages were 63.4, 98.9, and 100 %, respectively. At the 'before skin incision' surgical stage, while lymphoscintigraphy (but not ICG) detected 33 node fields, ICG (but not lymphoscintigraphy) detected only four node fields. The detection rates varied from 100 % in the groin region drained from trunk to 15.8 % in the axillary region from upper limb. The factors that influenced the failure of ICG to identify hot SLNs were an axillary node field (p < 0.001) and a high body mass index (BMI) (p = 0.046). CONCLUSION: For reliable identification of SLNs in cutaneous melanoma, the ICG fluorescence technique may offer little benefit for patients with axillary node field drained from upper limb, or high BMI.
BACKGROUND: Although several reports have discussed the potential of the indocyanine green (ICG) fluorescence technique, its effectiveness and limitations have not been fully evaluated. For the accurate detection of sentinel lymph node (SLN) in cutaneous melanoma, which can arise in a wide variety of sites throughout the body, it is important to detect the SLN sites prior to skin incision. The purpose of this study was to evaluate the ICG fluorescence technique in the preoperative setting. PATIENTS AND METHODS: We classified the detection process of SLN biopsy into three surgical stages: 'before skin incision,' 'after skin incision,' and 'ex vivo.' We retrospectively reviewed 93 node fields in 86 patients who underwent SLN biopsies using ICG and conventional techniques. RESULTS: The detection rate using ICG at the 'before skin incision,' 'after skin incision,' and 'ex vivo' surgical stages were 63.4, 98.9, and 100 %, respectively. At the 'before skin incision' surgical stage, while lymphoscintigraphy (but not ICG) detected 33 node fields, ICG (but not lymphoscintigraphy) detected only four node fields. The detection rates varied from 100 % in the groin region drained from trunk to 15.8 % in the axillary region from upper limb. The factors that influenced the failure of ICG to identify hot SLNs were an axillary node field (p < 0.001) and a high body mass index (BMI) (p = 0.046). CONCLUSION: For reliable identification of SLNs in cutaneous melanoma, the ICG fluorescence technique may offer little benefit for patients with axillary node field drained from upper limb, or high BMI.
Authors: Charles M Balch; Donald L Morton; Jeffrey E Gershenwald; Kelly M McMasters; Omgo E Nieweg; Barry Powell; Merrick I Ross; Vernon K Sondak; John F Thompson Journal: J Am Acad Dermatol Date: 2009-05 Impact factor: 11.527
Authors: Liang-Chih Liu; Brian M Parrett; Tyler Jenkins; Wayne Lee; Eugene Morita; Patrick Treseler; Laura Huang; Suresh Thummala; Robert E Allen; Mohammed Kashani-Sabet; Stanley P L Leong Journal: Ann Surg Oncol Date: 2011-04-06 Impact factor: 5.344
Authors: Karol Polom; Dawid Murawa; Young-Soo Rho; Piotr Nowaczyk; Michael Hünerbein; Pawel Murawa Journal: Cancer Date: 2011-04-11 Impact factor: 6.860
Authors: J J Albertini; C W Cruse; D Rapaport; K Wells; M Ross; R DeConti; C G Berman; K Jared; J Messina; G Lyman; F Glass; N Fenske; D S Reintgen Journal: Ann Surg Date: 1996-02 Impact factor: 12.969
Authors: Jennifer J Mueller; Lawrence T Dauer; Rajmohan Murali; Alexia Iasonos; Neeta Pandit-Taskar; Nadeem R Abu-Rustum; Jan Grimm Journal: J Nucl Med Date: 2020-01-10 Impact factor: 10.057
Authors: Charlotte M C Oude Ophuis; Lisa B Koppert; Cécile de Monyé; Carolien H M van Deurzen; Senada Koljenović; Alexander C J van Akkooi; Cornelis Verhoef; Dirk J Grünhagen Journal: BMC Cancer Date: 2017-04-12 Impact factor: 4.430
Authors: Ingo Stoffels; Philipp Jansen; Maximilian Petri; Lukas Goerdt; Titus J Brinker; Klaus G Griewank; Thorsten D Poeppel; Dirk Schadendorf; Joachim Klode Journal: JAMA Netw Open Date: 2019-08-02